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Abstract 
 
Multi-component reactions are a very elegant and rapid way to access highly functional 
molecules from simple building blocks in drug lead synthesis. Multi-component one-pot 
reactions generally afford good yields which is important in combinatorial synthesis. 
Over the past decade, several sequential multi-component reactions have been developed 
into multi-component one-pot reactions. Since multi-component one-pot reactions results 
in a reduced number of operations, they usually allows direct transformation of 
intermediates to desired products by avoiding isolation, handling and chromatography. 
Hence, better yields are usually achieved. 
 
In this study 1,4-disubstituted 1,2,3-triazoles were obtained by a high-yielding copper (I) 
catalyzed 1,3-dipolar cycloaddition reaction between in situ generated azides and 
terminal acetylenes. This one-pot, two-step procedure tolerated most functional groups 
and circumvented the problems associated with the isolation of potentially toxic and 
explosive organic azides. All of these factors are important in combinatorial synthesis of 
drug lead compounds. 
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Abbreviations 
 
13C NMR    Carbon nuclear magnetic resonance 
CDCl3     Deuterated chloroform 
DMSO     Deuterated methylsulfoxid 
EtOAc     Ethylacetate 
EtOH     Ethanol 
GTP     Guanosine 5-triphosphate 
H     Hydrogen 
1H NMR    Hydrogen nuclear resonance 
HRMS     High resolution mass spectrometry 
HTS     High throughput screening 
Hz     Hertz 
J     Coupling constant 
MeOH     Methanol 
Mp     Meltingpoint 
[M+]     Molecular ion 
NaAscorbate    Sodium ascorbate 
PABA     Para-aminobenzoic acid 
Rf     Retention factor 
t-BuOH    tert-buthanol 
TLC     Thin layer chromatography 
α     Alfa 
β     Beta 
d     Doublet 
q     Quartet 
s     Singlet 
t     Triplet 
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1. Drug development 
 
1.1 Introduction 
 
Even though we have come a long way in discovering drugs in many areas of human 
diseases, there is still a great demand for new and better drugs. New illnesses come along 
that need new drugs to combat them, and drugs that were once efficient are now futile 
against many common diseases. This might, for example, be due to resistance among 
bacteria. Other reasons to develop new drugs can be that the synthesis of the existing 
drug is difficult, expensive or harmful to the environment. Some drugs also have 
unacceptable side effects to go along with their wanted effects. Side effects might be 
minimized by altering the molecule slightly.  
 
Pharmaceutical companies and academic milieus are constantly putting in a great effort to 
discover new pharmaceutical compounds. This is a very laborious task, which in many 
cases is done practically “blindfolded” in a trail and error manner. This means that one 
needs a vast amount of compounds.  
 
A typical new pharmaceutical compound costs in the area of $800 mill. to develop from 
idea to a product ready for marketing (2001).1 Any enhancement in any step of the 
development of novel drugs would be of great value to any pharmaceutical company. If 
there is a way to avoid one step in the synthesis and purification process, a lot of money 
would be saved. This is why a synthetic reaction that is facile and high yielding would be 
suitable for preparing a vast amount of new compounds. To screen a large number of new 
compounds for possible effects one would need a tremendously large number of workers 
or a smart method. High throughput screening (HTS) allows you to investigate thousands 
of compounds each day. The principles of HTS will be further discussed later. 
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1.2 Combinatorial chemistry: 
 
All of the 10 largest selling drugs in 1994 were small organic molecules, i.e., compounds 
with molecular weights less than 700 daltons. 2 Due to this fact, much of the efforts of 
drug discovery are focused on small, organic molecules. To synthesize a reasonable 
library of compounds it is important to synthesize a great number of them. The traditional 
methods of organic chemistry limits chemists productivity a lot. A way to solve this 
problem is to do multiple reactions simultaneously. To do multiple reactions at the same 
time there are two key challenges that has to be met. First you have to develop reactions 
that are reliable and constantly produce satisfactory yields. The reactions should also be 
compatible with a large number of starting materials. Once you have found your 
preferred reactions, you need to develop a method to efficiently detect and identify your 
products.  
 
And the generation of molecular diversity by chemical synthesis is also important in drug 
discovery. The generation of molecular diversity is also based on the concepts of peptide 
synthesis. It was first reported by Merrifield3 in 1963 that it was possible to obtain good 
yields and simple isolation techniques by using  polymeric supports for the synthesis of 
peptides.  
 
Simultaneous synthesis of many products at the same time in multiple reaction vessels, 
often on a plate, is known as parallel synthesis. The concept is to mix and react two 
different groups of molecules, for example amines and carboxylic acids. For simplicity, 
let us consider a plate that has 4x4 wells. We have 4 amines: A1-A4 and 4 carboxylic 
acids: B1-B4. Each amine goes in a horizontal row. And each carboxylic acid goes in a 
vertical row. (See Figure 1) As seen in fig.1, we end up with a total of 16 products. 
 
A1B1 A1B2 A1B3 A1B4 
A2B1 A2B2 A2B3 A2B4 
A3B1 A3B2 A3B3 A3B4 
A4B1 A4B2 A4B3 A4B4 
Figure 1: Parallel synthesis 
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 In combinatorial synthesis one perform multiple reactions in the same vessel. An 
example of the simplest way to perform a combinatorial synthesis is one vessel filled 
with multiple reactants. If we mix two acids and five amines in a vessel to perform a 
amide reaction, we would end up with 2x5= 10 products.. An advance in combinatorial 
chemistry came with the portion-mixing approach described by Furka in 19884. This 
method is known as the split and mix method. Using this method, we mix the two acids 
and divide the mixture into five vessels where we add the five different amines into each 
one. We produce a library of compounds that exist in several mixtures. These mixtures 
are suitable for analysis with assays. The split and mix method can be utilized to make 
vast compound libraries in a short period of time.   
 
In the two techniques described above it is common to attach the reactants to a solid 
phase. The solid phase can be beads made of polymeric material.  This eases the process 
of isolation as well as giving higher yields, and also renders purification unnecessary. 
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1.3 High throughput screening 
 
To be able to analyze the enormous number of compounds obtained by using 
combinatorial chemistry, a powerful method is needed. A HTS system is built around a 
plate with small wells, where samples and assay reagents are deposited. The aim of the 
assays is to detect “hits”. A “hit” is a positive result. There can be a variety of detector 
systems. They can detect radioactivity, luminescence or fluorescence for example. 
Detection of such signals indicates a “hit”, and the strength of them indicate the quality of 
the “hit”. MS detection is also used to identify products, even on single beads taken from 
a sample.5 If a “hit” is detected, the chemist has to look closer at the compounds in the 
well that produced the “hit”. 
 
A HTS system is often set up to be automated. The use of robotics is both time and cost 
effective. The chemists’ job is to find the appropriate assay to the library compounds and 
program the robotics to deliver the needed samples to the wells on the plate.  
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1.4 Click chemistry 
 
Professor K. B. Sharpless and co-workers at The Scripps Research Institute in 2001 
introduced click chemistry as guiding principles for organic synthesis. Click chemistry 
was their response to the problems associated with making reliable libraries of potential 
lead structures using combinatorial chemistry. Click chemistry is a modular approach to 
chemical synthesis that utilizes only the most practical and reliable chemical 
transformations.  
 
To fit into the category of click chemistry a reaction has to meet certain requirements. 6,7  
 
1: It has to be a facile and selective reaction.  
2: It must be of a wide scope, meaning that it will provide high yields from a large 
variety of starting compounds consistently. 
3: It must be easy to perform and insensitive to water and oxygen. 
4: It must use only readily available reagents. 
5: The reaction has to be easy to work up and the product isolation must be simple, 
without requiring any chromatography. 
 
 
Its applications are increasingly found in all aspects of drug discovery, ranging from lead 
finding of new drug candidates through proteomics as well as DNA research utilizing 
bioconjugation reactions.  
 
Despite many successes, drug discovery approaches that are based on Nature’s secondary 
metabolites, i.e. natural products, are often hampered by slow and complex synthesis of 
drug candidates. Through the use of only the most facile and selective chemical 
transformations, click chemistry simplifies synthesis and purification in medicinal 
chemistry based on natural products. This will enable faster discovery of lead molecules, 
as well as speed up the optimization of existing biologically active compounds that 
targets a specific receptor. Thus, click chemistry is a set of powerful, virtually 100% 
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reliable, selective reactions for rapid synthesis of a vide variety of biologically active 
compounds. 
 
Click chemistry uses carbon-heteroatom bond-forming connection chemistry.6 In click 
chemistry the focus is on highly energetic reactants and kinetic control of the reaction, 
hence click chemistry reactions are also irreversible.  
 
Click reactions utilizes benign reaction conditions. They should work very well in water 
and in the presence of oxygen. This is a great advantage because it limits the use of 
environmentally unfriendly solvents used in “traditional” chemical synthesis. The fact 
that the reactions are insensitive to oxygen makes them a whole lot easier to perform. 
There is no need to do them under argon or nitrogen. This limits the effort required. A 
huge advantage of click chemistry is that they use strongly driven and highly selective 
reactions. The reactions are run at neutral pH or slightly alkaline pH.  
 
Another benefit is that the triazole ring is not just a passive link, it interacts with 
biological targets through hydrogen bonding and dipole interactions.6 Many 
pharmaceutical compounds include heterocycles as a functional group. Click chemistry 
gives access to a vast variety of five and six membered heterocycles through such 
reactions as hetero Diels-Alder and 1,3-dipolar cycloadditions8. 
 
The 1,4-disubstitiuted 1,2,3-triazoles prepared by a copper-(I)-catalyzed reaction between 
terminal alkynes and azides (Figure 2),9 is an example of a synthesis that produces one of 
the hetero cycles mentioned above. This reaction seems well suited for medicinal 
chemistry for the rapid development of drug lead compounds. The regioisomeric product 
formed, the 1,4-disubstituted 1,2,3-triazole, shares topological and electronic features 
with Nature’s ubiquitous amide connectors. Unlike amides, triazoles are not susceptible 
to cleavage and are hence stable both in vitro and in vivo. 
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ON
H
R1
R2 ~ N
NN
R2R1
5.0 Å3.8 Å
Dipole moment: ~ 5.0 Debye
N2 and N3: Weak H bond acceptors
Difficult to oxidize or reduce
Hydrolytically stable
Precipitates easily in aquous solutions
1,4-Disubstituted 1,2,3-triazoles could serve as amide linkers
Physical and chemical properties:
 
Figure 2: Amides and 1,2,3-triazoles share topological and electronic features 
 
 
Given the readily access to the starting azides and terminal alkynes, highly diverse and 
unambiguous lead compounds should become available quickly, since there are no need 
for protection and deprotection steps under click chemistry conditions. Furthermore, with 
complete conversion of starting materials and with exclusive selectivity for the 1,4-
disubstituted 1,2,3-triazoles, the process of identification and discovery of new drug lead 
compounds, as well as optimization of existing ones, should become more efficient. 
 
Because click chemistry relies on a small number of near perfect reactions there is some 
concern that there will be limits to the potential chemical diversity of the compound 
libraries obtained by using the procedures. In a computational study by Guida et al. it is 
suggested that the number of drug like compounds are as large as 1063.10  A drug like 
compound has less than 30 non H-atoms, a size less than 500 daltons and includes only 
H, C, N, O, P, S, F, Cl and Br and they must be likely to be stable in presence of water 
and oxygen.  At this point somewhere between 106 and 107 such molecules are known. 
This means that only a very small part of the potential drugs have been discovered. Click 
chemistry can’t explore all of these possibilities, but it is a fast and effective way to 
explore a huge number of interesting molecules that can be made with relative ease. In 
this way research can focus on the part of the 1063 different molecules that are easy to 
make and isolate rather then starting with the ones that requires complex synthesis. 
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 The Huisgen 1,3-dipolar cycloadditions of azides and alkynes to give triazoles, is a useful 
cycloaddition reaction that gives heterocycles.11 Even though the reaction is favored 
kinetically, it may require elevated temperature and it usually results in a mixture of the 
1,4 and 1,5 regioisomers. 
 
 
Figure 3: Regioisomers of 1,2,3-triazoles11(Reprinted) 
 
Efforts to control this 1,4- versus 1,5 regioselectivity problem was met with various 
success until the copper(I)-catalyzed reaction was discovered.11 While a number of 
copper(I) sources can be used, it was found that the catalyst was better prepared in situ by 
reduction of copper(II) salts. Copper sulphate serves well as a source. As the reductant, 
ascorbic acid or sodium ascorbate proved to be excellent.  With 0.25-2% mol of the 
copper(I) catalyst the reaction is regiospecific at ambient temperatures and yields only the 
1,4-disubstituted 1,2,3-triazoles.11 
 
The mechanism proposed by Rostovtsev et al. is shown in Figure 4. It starts with the 
formation of the copper (I) acetylide. Functional theory calculations and experimental 
work published by Sharpless et al. in 200512  points to a stepwise, annealing sequence 
rather than the concerted [2+3] cycloaddition.  
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Figure 4: Mechanism of copper(I) catalysis. Reprinted11 
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1.5 Synthesis of starting compounds 
 
Terminal alkynes can be synthesized in numerous ways. Some common procedures will 
be outlined here.  
 
McKelvie reported the synthesis of 1,1-dibromoolefins (ylide) via phosphine-
dibromomethylenes in 1962.13 (Figure 5) This discovery was important for future work. 
 
 
 
C B r4 2  (C 6 H 5 )3 P (C6H5)3P CBr2 (C 6 H 5 )3 PB r2 
C6H5
C6H5 C CBr2
H
C O 
H
(C 6 H 5 )3 P O 
Figure 5: A 1,1-dibromoolefin 
 
 
In 1972 Corey and Fuchs synthesized terminal alkynes from aldehydes.14 The synthesis 
involves 2 steps. (Figure 6) Notice that the first step is the same as in Figure 5. 
 
 
R H
O
Ph3P, CBr4
Br Br
RH
1. BuLi
2. H2O R  
Figure 6: Corey-Fuchs synthesis of terminal alkynes 
 
Colvin and Hamill reported a one-step conversion of carbonyl compounds into acetylenes 
in 1973.15 (Figure 7) 
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Figure 7: Colvin and Hamill conversion. 
 
Ohira reported a useful means of preparing dimethyl (diazomethyl)-phosphonate.16  
(Figure 8) 
 
O
N2
P
O
OCH3
OCH3
H
N2
P
O
OCH3
OCH3
0.2 eq. K2CO3
MeOH, 0ºC
 
Figure 8 
 
Bestmann reported a one pot procedure for preparing terminal alkynes with the reagent 
dimethyl-1-diazo-2-oxopropylphoshonate.17 (Figure 9) 
 
 
 16
ON2
P
O
OCH3
OCH3
r.t., 4-16t
R
O
H
K2CO3, MeOH
R
 
Figure 9 
 
Azides are readily accessible through numerous reactions. One way to obtain azides are 
nucleophilic substitution reactions. (SN2 type.) These and other ways to obtain azides are 
thoroughly reviewed in “Organic Azides: An Exploding Diversity of a Unique Class of 
Compounds”.18 
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1.6 Tubulin and tubulin inhibitors 
 
Every nucleated cell in the human body contains two similar spherical proteins called α 
and β tubulin. These two come together to form an α- β heterodimer. These heterodimers 
can, in the presence of GTP at 37oC, form long protein fibers called protofilaments. 
These protofilaments group together and curl up to form pipe-like structures called 
microtubules.19 The microtubules give the cell support, acting like a scaffold. They also 
organize the organelles of the cell. The most important role of the microtubules is the 
formation of the mitotic spindle. The mitotic spindle is involved in the cell replication 
process, where it “pulls” the chromosomes towards opposite sides of the dividing cell. 
(Figure 10) 
 
 
Figure 10: Microtubules in mitosis. Reprinted20 
 
In cancer cells the cell replication process is out of control.19 One target for controlling 
the growth of a tumor is therefore to inhibit the formation of microtubules. There are 
separate classes of drugs that bind to tubulin. All tubulin inhibiting substances are divided 
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fit into classes depending upon the effect which that substance exerts on the binding site 
of five characterized tubulin agents to tubulin. These agents are colchicine, vincristine, 
vinblastine, rhizoxin and myatansine.19  
 
Combretastatin A-4(Figure 11) is isolated from the South African Willow, Combretum 
caffrum, and has a simple chemical structure that shows antimitotic effect by interaction 
with the colchicine binding site on tubulin.21 Combretastatin A-4 has shown an 
impressive spectrum of activity, including inhibition of angiogenesis, which is essential 
for tumor growth.22 Combretastatin A-4 has been considered for clinical trails, but these 
met an obstacle due to the poor water solubility of the drug. There is currently being done 
a lot of research to make analogues that overcome this problem. 
 
 
MeO
MeO
OMe
OMe
OH
 
Figure 11: Combretastatin A-4 
 
 
 
 
 
 
 
 
 
 
 
 19
  
 
1.7 Sulfonamides 
 
In the early 1930s Gerhard Domagk tested a variety of azo dyes for antibacterial activity. 
Prontosil showed significant results in test. The dye successfully protected mice against 
streptococcal infections.23 Later Tréfouël found that prontosil was not active in vitro, but 
when a reducing agent was added the drug was active.24 It was found that prontosil 
needed to be reduced to sulfanilamide to be active. The discovery of prontosil, and its 
properties, marks the beginning of modern chemotherapy and structure-activity 
relationship studies.  
 
A breakthrough in the discovery of the mechanism of action for the sulfonamides was 
made in 1940 by Woods.25 He showed that the p-aminobenzoic acid was a potent 
inhibitor of sulfanilamide induced bacteriostasis in streptococcal infected mice. Finally, 
Miller demonstrated that sulfanilamide inhibited the folic acid biosynthesis, that is critical 
for the growth of bacteria.26 
 
A major concern with the use of sulfonamide drugs is the development of drug resistance. 
One mechanism of drug resistance is that the bacteria develop an enzyme that is less 
sensitive to sulfonamides than p-aminobenzoic acid.27 Another mechanism involves 
altered permeability to the sulfonamides.28 Synthesis of analogues that avoid these 
problems could prove very valuable.  
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Figure 12: Biochemical reaction catalyzed by dihydropteroic synthetase29 (reprinted). 
 
Biochemical synthesis of dihydropteroic acid is shown in Figure 12. The various 
sulfonamide analogs inhibit this synthetic pathway by competitive inhibition of PABA. 
The sulfonamides have a similar structure to PABA and therefore they can interfere in the 
reaction shown in Figure 12. Dihydropteroic acid is essential to the formation of folic 
acid that is required as precursors in the synthesis of both DNA and RNA in bacteria and 
mammals. 
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1.8 Aim of study 
 
In the present study it is sought to synthesize 1,2,3-triazole analogues of combretastatins 
and antibacterial sulfonamides. In addition, another aim was to see if new one-pot click 
chemistry procedures could be developed.  
OH
OMe
OMe
MeO
MeO
Combretastatin A-4 MeO
MeO
OMe
N
N
N
HO O
O
Click chemistry
MeO
OMe
OMe
HO
N3
O
O
 
Figure 13: Example of synthesis of a combretastatin analogue 
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N O
O
BrOBr
S
O
O
N
H
H
N O
O
Br
O
N
N N
Click chemistry
H2N SO2NH2
Sulfanilamide
 
Figure 14: Example of synthesis of a sulfanilamide analogue 
 
 22
2. Results and Discussion 
 
2.1 Syntheses 
 
2.1.1 Syntheses of alkynes 
 
The first object of the study was to synthesize the starting materials. To obtain alkynes a 
reduction from 3,4,5-trimethoxybenzaldehyde to (3,4,5-trimethoxyphenyl)methanol (1) 
was performed, as outlined in Equation 1. 
MeO
OMe
OMe
CH2OH
MeO
OMe
OMe
CHO
NaBH4
EtOH:H2O, 1:1
THF
 
Equation 1 
                                                                                                                        1 (100%)  
 
The product had a Rf in hexane:EtOAc (2:1) of  0.13. 1H NMR spectra of the product 
showed a singlet at 6.58 ppm with an integral height of 2 that indicated two aromatic 
protons. A singlet at 4.62 ppm with an integral height of 2 indicated two protons in α-
position to a benzene ring. Two singlets at 3.85 ppm and 3.82 ppm with integral heights 
of 6 and 3 indicated nine methyl protons. There was no signal for the proton on the 
alcohol group. 13C NMR data showed a peak at 153.30 ppm that indicated two aromatic 
carbons. Two peaks at 137.23 ppm and 136.63 ppm representing two aromatic carbons. 
At 103.75 a peak represented two aromatic carbons. A peak at 65.43 ppm indicates an 
aliphatic carbon. At 60.80 ppm and 56.03 ppm two peaks for the three methyl carbons 
were shown.  
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The product 1 was used to synthesize 5-(bromomethyl)-1,2,3-trimethoxybenzene (2), as 
shown in Equation 2
MeO
OMe
OMe
CH2Br
MeO
OMe
OMe
CH2OH
 
Equation 2 
           2 (58%) 
 
The melting point of 2 determined to 74-75oC. Rf in hexane:EtOAc (9:1): 0.65; 1H NMR 
spectra of the product 2 showed a singlet at 6.62 ppm with an integral height of 2 that 
indicated two aromatic protons. A singlet at 4.46 ppm with an integral height of 2 
indicated two protons in α position to a carbon-carbon double bond. Two singlets at 3.87 
ppm and 3.84 ppm with integral heights of 6 and 3 indicated nine methyl protons. 
 
The product 2 was used in an attempt to synthesize 1,2,3-trimethoxy-5-(prop-2-
ynyl)benzene (3), as shown in Equation 3. 
MeO
OMe
OMe
CH2Br
MeO
OMe
OMe
MgBrCCH
CuI, 0oC
 
Equation 3 
          3 (0%) 
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The reaction outlined in Equation 3 was monitored by TLC after 1 hour there was no sign 
of formation of the product. The temperature was elevated to 58oC and the mixture was 
left to stir for 48 h. A new test by TLC showed that no product was formed and the 
experiment was aborted. 
 
A Grignard reaction to obtain a terminal alkyne, as outlined in Equation 4, was 
performed. 
OMe
OMeMeO
OMe
MeO
O
OHMe
CuI, 0oC
HO
MgBrCCH
 
Equation 4 
          4 (88%)   
 
The product 1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol (4) obtained was not pure. After 
column chromatography, an 88% yield of 4 was collected. Rf in hexane:EtOAc (1:1): 
0.42. 1H NMR spectra of the product showed a singlet at 6.80 ppm with an integral height 
of 2 indicated two aromatic protons. A singlet at 5.42 ppm with an integral height of 1 
indicated a methinine proton. Two singlets at 3.89 ppm and 3.85 ppm with integral 
heights of 6 and 3 indicated nine methyl protons. A doublet at 2.69 ppm (J 2.1 Hz) 
indicated an alcohol proton. 13C NMR data showed a peak at 153.87 ppm that indicated 
two aromatic carbons. Two peaks at 138.10 ppm and 135.56 ppm represented two 
aromatic carbons. At 103.64 a peak represented two aromatic carbons. Two peaks at 
83.56 ppm and 74.89 ppm indicated two acetylene carbons. At 64.56 ppm a peak 
indicated an aliphatic carbon. At 60.84 ppm and 56.15 ppm two peaks for the three 
methyl carbons were shown. This confirmed the structure of 4. 
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Another terminal alkyne was prepared, this time utilizing dry conditions. The reaction 
(Equation 5) produced 5-ethynyl-1,2,3-trimethoxybenzene (5) in 64% yield after 
purification by column chromatography.  
 
H3CO
OCH3
OCH3
O
H3CO
OCH3
OCH3
C4H10N2Si
[(CH3)2CH]2NLi,
-78oC
THF
 
Equation 5 
          5 (64%) 
 
The melting point of 5 was found to be 93-95oC. Rf in hexane:EtOAc (8:3): 0.50. 1H 
NMR spectra of the product showed a singlet at 6.73 ppm with an integral height of 2 that 
indicated two aromatic protons. A singlet at 3.85 ppm with an integral height of 9 
indicated nine methyl protons. A singlet at 3.03 ppm with an integral height of 1 
indicated an acetylene proton. 13C NMR data showed a peak at 153.04 ppm that indicated 
two aromatic carbons. Two peaks at 139.30 ppm and 117.01 ppm represented two 
aromatic carbons. At 109.36 a peak represented two aromatic carbons. Two peaks at 
83.70 ppm and 76.19 ppm indicated two acetylene carbons. At 60.95 ppm and 56.15 ppm 
two peaks for the three methyl carbons were shown. HRMS data showed that molecular 
ion was observed at 192.0780 daltons. This confirmed the structure of 5. 
 
An example of a N-acylation of propargylamine with an acyl chloride to yield ethyl prop-
2-ynylcarbamate (6) is shown in Equation 6.30 
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H2N
O
O Cl
N
H
O
O
CH2Cl2
 
Equation 6 
          6 (0%) 
 
A NMR of the product (6) indicated that only starting materials was isolated. 
 
The N-acylation of propargylamine was performed in the same matter as shown in 
Equation 6 using a sulfanilylchloride as the other reagent. This reaction is shown in 
Equation 7. 
H2N
S
O
O
N
H
H
N O
S
O
O
H
N O
Cl
Pyridine
0oC
 
Equation 7 
          7 (43%) 
 
The reaction yielded N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (7). This reaction 
was performed both on a small scale and a larger scale, using 2 mmol and 45 mmol of 
propargylamine. The yields were 24% for the small scale reaction and 43% for the larger 
scale reaction. The structure of the product 7 was assigned based on NMR and MS data 
as well as the melting point. The melting point was determined to 192-193oC. Rf in 
hexane:EtOAc (1:5): 0.40. 1H NMR spectra of the product showed a singlet at 9.50 ppm 
with an integral height of 1 that indicated a sulfonamide proton. A multiplet at 7.84-7.77 
ppm with an integral height of 4 indicated four aromatic protons. A multiplet at 3.81-3.79 
ppm with an integral height of 2 indicated two methylene protons. A singlet at 2.12 ppm 
with an integral height of 3 indicated 3 methyl protons. A singlet at 2.09 ppm with an 
integral height of 1 indicated a secondary amine proton. 13C NMR data showed a peak at 
170.50 ppm that indicated an amide carbon. Four peaks at 145.15 ppm, 136.45 ppm, 
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130.08 and 120.37 indicated six aromatic carbons. Two peaks at 80.73 ppm and 74.63 
ppm indicated two acetylene carbons. Two peaks at 34.13 ppm and 25.38 ppm indicated 
two aliphatic carbons. HRMS data showed the molecular ion at 252.0565. This confirmed 
the structure of 7. 
 
 
S
O
O
N+
O
O-
HN
S
O
O
N+
O
O-
Cl
NH2
H2O, pH 8
20oC  
Equation 8 
          8 (61%) 
 
The structure 4-nitro-N-(prop-2-ynyl)benzenesulfonamide (8) was assigned based on 
NMR and MS data as well as the melting point. The melting point was determined to 
152-154oC. Rf in hexane:EtOAc (2:1): 0.33. 1H NMR data showed a triplet at 8.54 ppm (J 
5.8) with an integral height of 1 that indicated a sulfonamide proton. Two multiplets at 
8.45-8.38 ppm and 8.09-8.04 ppm with integral heights of 2 represented four aromatic 
protons. A doublet of a doublet at 3.79 ppm (J 2.6) with an integral height of 2 
represented two aliphatic protons. A triplet at 3.01 ppm (J 2.6) with an integral height of 
1 represented an acetylene proton. 13C NMR data showed four peaks at 149.53 ppm, 
146.18 ppm, 128.34 ppm, 124.29 ppm that represented six aromatic carbons. Two peaks 
at 78.72 ppm and 75.09 ppm represented two acetylene carbons. A peak at  31.81 ppm 
indicated an aliphatic carbon. 
 
An alkaline hydrolysis of 7 to yield 4-amino-N-(prop-2-ynyl)benzenesulfonamide (9) was 
performed as outlined in Equation 9. 
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Equation 9 
        9 (0%) 
 
TLC of the reaction mixture showed that a product was formed, but there were 
difficulties with the isolation of the product. It would not be distributed in the organic 
phase when an extraction with chloroform and water was attempted. The water phase was 
evaporated under reduced pressure and the resulting solid was dissolved in methanol. The 
solution was filtered through a “plug”. (Figure 15) 
 
 
Figure 15: The plug used for filtration of  8 
 
The methanol was evaporated under reduced pressure. The crude product was believed to 
be a mixture of  9 and sodium chloride, where the sodium chloride originated from the 
neutralization of the reaction mixture with hydrochloric acid. Rf in hexane:EtOAc (1:4) 
was 0.38. 1H NMR spectra of the product 9 showed a doublet at 7.53 ppm (J 8.7 Hz) with 
an integral height of 2 that indicated two aromatic protons. A doublet at 6.69 ppm (J 9.0 
Hz) with an integral height of 2 indicated two aromatic protons. A doublet at 3.65 ppm (J 
2.7 Hz) with an integral height of 2 indicated two methylene protons. A triplet at 2.47 
ppm (J 2.7 Hz) with an integral height of 1 indicated a secondary amine proton. A singlet 
at 2.16 ppm with an integral height of 1 indicated an acetylene proton. 13C NMR data 
showed four peaks at 154.28 ppm, 130.92 ppm, 127.12 and 114.43 that indicated six 
aromatic carbons. Two peaks at 79.93 ppm and 73.34 ppm indicated two acetylene 
carbons. At 33.18 ppm a peak indicated an aliphatic carbon. The NMR data showed that 
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the product was formed, but there were difficulties with the isolation of the product. 
HRMS data indicated a molecular ion at 210.0457. 
 
2.1.2 Syntheses of azides. 
 
Several azides were synthesized by nucleophilic substitution (SN2 type). Ethyl 2-
azidoacetate (10) was synthesized as outlined in Equation 10.  
NaN3
O
OBr EtOH:H2O (1:1)
O
ON3  
Equation 10 
          10 (55%) 
 
1H NMR spectra of the product 10 showed a quartet at 4.24 ppm (J 6.9 Hz) with an 
integral height of 2 that indicated two aliphatic protons. A singlet at 3.84 ppm with an 
integral height of 2 represented the two protons in α-position to the azido group. A 
doublet 1.29 ppm (J 6.9 Hz) with an integral height of 3 indicated three methyl protons. 
13C NMR data showed a peak at 168.21 ppm that represented a carboxylic carbon. Two 
peaks at 61.79 ppm and 50.29 ppm represented two aliphatic carbons. A peak at 14.05 
represented a methyl carbon. HRMS data indicated the molecular ion at 129.0539. IR 
data showed signals at 2109 cm-1 for the azido group and 1747 cm-1 for the carbonyl 
carbon. This confirmed the structure of 10. 
 
 
Synthesis of (azidomethyl)benzene (11). (Equation 11) 
 
Br N3
NaN3
EtOH:H2O (1:1)
 
Equation 11 
               11 (86%) 
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The product 11 had a Rf of 0.80 in hexane:EtOAc (2:1); 1H NMR spectra showed 
multiplet at 7.43-7.30 ppm with an integral height of 5 that indicated five aromatic 
protons. A singlet at 4.35 ppm with an integral height of 2 represented the two protons in 
α-position to the azido group. 13C NMR data showed four peaks at 135.35, 128.82, 
128.29 and 128.20 ppm that represented six aromatic carbons. A peak at 54.80 ppm 
represented a carbon α-position to the azido group. The product was a yellow liquid. 
  
Synthesis of 1-(azidomethyl)-4-nitrobenzene (12) (Equation 12). 
 
NaN3
N+
O O-
Br
N+
O O-
N3
EtOH:H2O (1:1)
 
Equation 12 
                  12 (89%) 
 
The product 12 had a Rf of 0.80 in hexane:EtOAc (2:1); 1H NMR spectra showed 
multiplet at 8.26-8.19 ppm with an integral height of 2 that indicated 2 aromatic protons. 
A multiplet at 7.58-7.48 ppm with an integral height of 2 indicated 2 aromatic protons. A 
singlet at 4.51 ppm with an integral height of 2 represented the two protons in α-position 
to the azido group. 13C NMR spectrum data showed four peaks at 144.74, 142.67, 129.89 
and 124.03 ppm that represented six aromatic carbons. A peak at 53.72 ppm represented 
a carbon α-position to the azido group. The product was a yellow liquid. HRMS indicated 
a molecular ion at 178.0490. 
 
In these experiments it was important to monitor the pH of the mixture before the NaN3 
was added. In acidic aqueous solutions NaN3 will produce the highly toxic and explosive 
HN3. The experiments were straight forward to perform, and the products were easily 
isolated via extraction with EtOAc and evaporation under reduced pressure.  
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Another method for preparation of azides was attempted. A direct conversion of activated 
alcohols to azides.31 (Equation 13 and Equation 14) 
 
OH
N
DBU
(PhO)2PON3
N3
N
 
Equation 13 
          13 (0%) 
 
DBU
(PhO)2PH2ON3
N3OH
N N
 
Equation 14 
          14 (0%) 
 
These two reactions proved difficult to perform and no product was isolated in either one 
of them. 
2.1.3 Desalting of 3-(bromomethyl-)pyridine hydrobromide 
 
An attempt to synthesize 3-(bromomethyl)pyridine (15) was made. (Equation 15)  
N
Br
NaOH
H2O:EtOH, 1:1
HBr
N
Br
x HBr
 
Equation 15 
           15 (0%) 
 
No product 15 was found when the reaction (Equation 15) was monitored with TLC.  
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2.1.4 Syntheses of bromides 
 
O
Br
Cl
HO
Br
O
BrOBr
Triethylamine
 
Equation 16 
          16 (30%) 
 
The product, 2-bromophenyl 2-bromoacetate (16) was obtained as a colorless liquid after 
column chromatography (Equation 16). The product 16 had a Rf of 0.60 in hexane:EtOAc 
(3:1). 1H NMR spectra showed a doublet at 7.62 ppm (J 7.8 Hz) with an integral height of 
1, a triplet at  7.35 ppm (J 8.1 Hz) with an integral height of 1 and a  multiplet at 7.18-
7.13 ppm with an integral height of 2. These three signals represented four aromatic 
protons. A singlet at 4.37 ppm with an integral height of 2 indicated two aliphatic 
protons. 13C NMR data showed a peak at 164.96 ppm that represented a carboxylic 
carbon. Six peaks at 147.62 ppm, 133.44 ppm, 128.59 ppm, 127.85 ppm, 123.31 ppm and 
115.71 ppm represented six aromatic carbons. At 25.05 ppm a peak indicated an aliphatic 
carbon.  
O
Br
Cl
O
Br
O
O
O
HO
O
O
triethylamine
 
Equation 17 
             17 (24%)     
 
Methyl 3-(4-(2-bromoacetoxy)phenyl)propanoate (17) was isolated after column 
chromatography (Equation 17). The product 17 had a Rf of 0.38 in hexane:EtOAc (3:1); 
1H NMR spectra showed a doublet at 7.23 ppm (J 8.7 Hz) with an integral height of 2 and 
a doublet at 7.05 ppm (J 8.7 Hz) with an integral height of 2. These two signals 
represented four aromatic protons. A singlet at 4.27 ppm with an integral height of 2 
indicated two aliphatic protons. A singlet at 3.67 ppm with an integral height of 3 
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indicated three methyl protons. A triplet at 2.96 ppm (J 8.1 Hz) with an integral height of 
2 represented 2 aliphatic protons. A triplet at 2.63 ppm (J 7.8 Hz) with an integral height 
of 2 represented two aliphatic protons. 13C NMR spectrum data showed two peaks at 
173.06 ppm and 165.91 that represented two carboxylic carbons. Four peaks at 148.71 
ppm, 138.71 ppm, 129.41 ppm and 121.07 ppm represented six aromatic carbons. At 
51.65 ppm a peak represented a methyl carbon. At 40.85 ppm, 35.52 ppm and 30.25 ppm 
three peaks indicated three aliphatic carbons.  
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2.2 Click reactions 
2.2.1 One pot syntheses 
 
Several one pot syntheses was performed to yield 1,4-disubstituted 1,2,3-triazoles. They 
were performed as described in general procedures for one-pot click reactions. The 
reactions and results are discussed below.  
 
MeO
MeO
OMe
N
N
N
O
O
MeO
OMe
OMe
O
Br
O
CuSO4
NaAscorbate
t-BuOH:H2O, 1:1
NaN3
 
Equation 18 
         18 (51%) 
 
The synthesis of ethyl 2-(4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-1-yl)acetate (18) 
did not go to completion after 12 hours of stirring at room temperature. Another 0.5 eqv. 
of the azide along with more of the sodium ascorbate and the copper sulphate catalyst 
was added and the mixture was allowed to stir for two more days.. The TLC still 
indicated traces of the starting materials. Total yield of the reaction was 51%. The 
melting point was determined to 95-97oC. Rf in hexane:EtOAc (1:10) was 0.66. 1H NMR 
spectra of the product 18 showed a singlet at 7.90 ppm with an integral height of 1 that 
represented the triazole proton. A singlet at 7.06 ppm with an integral height of 2 
represented two aromatic protons. A singlet at 5.20 ppm with an integral height of 2 
indicated two aliphatic protons. A quartet at 4.29 ppm (J 7.8 Hz) with an integral height 
of 2 represented two aliphatic protons. Two singlets at 3.92 ppm and 3.87 ppm with 
integral heights of 6 and 3 indicated nine protons on the methoxy groups. A triplet at 1.31 
ppm (J 7.8 Hz) with an integral height of 3 represented three methyl protons. 13C NMR 
spectrum data showed a peak at 166.27 ppm that represented a carboxylic carbon. Three 
peaks at 153.62 ppm, 138.24 ppm and 125.84 ppm represented four aromatic carbons. At 
120.77 ppm a peak indicated a triazole carbon. At 103.04 a peak indicated two aromatic 
 35
carbons. At 62.50 a peak represented an aliphatic carbon. At 60.92 ppm and 56.24 ppm 
two peaks represented the three carbons in the methoxy groups. At 50.97 ppm and 14.06 
ppm two peaks indicated two aliphatic carbons. A peak for the second triazole carbon 
was not found in the spectrum. HRMS data indicated a molecular ion at 321.1330. 
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O
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O
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Equation 19 
              19 (0%) 
 
NMR data of ethyl 2-(4-(hydroxy(3,4,5-trimethoxyphenyl)methyl)-1H-1,2,3-triazol-1-
yl)acetate (19) (Equation 19) showed that only starting materials were isolated. 
 
Synthesis of diethyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)malonate (20) outlined in Equation 
20.  
O
O
O
O
Br
NaN3
CuSO4,
NaAscorbat
N
N
N
O
O
O
O
H2O:t-BuOH, 1:1
 
Equation 20 
         20 (25%) 
 
The NMR data showed that the product (20) obtained was not pure. (Equation 20) 
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Equation 21 
         21 (36%)  
 
The NMR data showed that ethyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)propanoate (21) 
obtained was not pure. (Equation 21) 
 
NaN3
CuSO4
NaAscorbate
t-BuOH:H2O, 1:1
N
N
N
O
O
Br
O
O
 
Equation 22 
         22 (61%) 
 
Synthesis of ethyl 2-phenyl-2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate (22) (Equation 22). 
NMR data showed that the product was not formed. 
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Equation 23 
     23 (38%) 
 
NMR data of 2-bromophenyl 2-(4-((4-acetamidophenylsulfonamido)methyl)-1H-1,2,3-
triazol-1-yl)acetate (23) (Equation 23) showed that no product was isolated. 
 
 
O
BrOBr
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CuSO4
NaAscorbate
O
BrO
N
N
N
t-BuOH:H2O, 1:1
 
Equation 24 
         24 (0%) 
 
Synthesis of 2-bromophenyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate (24). (Equation 
24) TLC monitoring of the reaction showed that no product was formed.  
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t-BuOH:H2O, 1:1  
Equation 25 
         25 (53%) 
 
Synthesis of ethyl 2-(4-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)acetate (25) (Equation 25). 
The melting point was determined to 144-145oC. Rf in hexane:EtOAc (1:4) was 0.66 
1H NMR spectra of the product 25 showed a singlet at 8.85 ppm with an integral height 
of 1 that represented the triazole proton. A doublet at 8.32 ppm (J 9.0 Hz) with an 
integral height of 2 represented two aromatic protons. A doublet at 8.14 ppm (J 9.0 Hz) 
with an integral height of 2 represented two aromatic protons. A singlet at 5.52 ppm with 
an integral height of 2 indicated two aliphatic protons. A quartet at 4.21 ppm (J 7.2 Hz) 
with an integral height of 2 represented two aliphatic protons. A triplet at 1.24 ppm (J 7.2 
Hz) with an integral height of 3 represented three methyl protons. 13C NMR data showed 
a peak at 166.98 ppm that represented a carboxylic carbon. At 146.59 ppm a peak 
indicated a triazole carbon. Two peaks at 144.38 ppm and 136.79 ppm represented two 
aromatic carbons. At 128.33 ppm a peak indicated a triazole carbon. At 125.94 ppm and 
124.23 ppm two peaks indicated four aromatic carbons. At 61.58 ppm and 50.63 ppm two 
peaks indicated two aliphatic carbons. At 13.89 ppm a peak indicated a methyl carbon.  
The reaction gave a mixture of the product and the starting materials. The starting 
materials showed up in the NMR spectrums. Hence, the yield was lower than expected 
for standard click reactions.  
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Equation 26 
         26 (42%) 
 
Synthesis of ethyl 2-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)acetate (26). (Equation 26) 
The reaction was straight forward, but the yield was lower than expected for standard 
click reactions. The melting point was found to be over 250oC. Rf in hexane:EtOAc (1:4) 
was 0.72; 1H NMR spectra of the product 26 showed a singlet at 8.68 ppm with an 
integral height of 1 that represented the triazole proton. A multiplet at 7.72-7.14 ppm 
with an integral height of 4 represented four aromatic protons. A singlet at 5.47 ppm with 
an integral height of 2 indicated two aliphatic protons. A quartet at 4.20 ppm (J 7.2 Hz) 
with an integral height of 2 represented two aliphatic protons. A triplet at 1.04 ppm (J 7.2 
Hz) with an integral height of 3 represented three methyl protons. HRMS data indicated 
the molecular ion at 249.0913.  
 
 
O
OBr
O O
N
N
N
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CuSO4
NaAscorbate
t-BuOH:H2O, 1:1
40oC
O2N
O2N
 
Equation 27 
         27 (87%) 
 
Synthesis of ethyl 2-(4-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)acetate (27) (Equation 27).  
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This reaction was a repetition of the one shown in Equation 25 with an elevated 
temperature. The temperature was now set to 40oC to see if it would result in a better 
yield. The yield was improved from 53% to 87%, which is in the range for a click 
reaction. The melting point was determined to 144-145oC. Rf in hexane:EtOAc (1:4) was 
0.66 1H NMR spectra of the product (27) showed a singlet at 8.84 ppm with an integral 
height of 1 that represented the triazole proton. Two doublets at 8.33 ppm (J 9.0 Hz) and 
8.14 ppm (J 9.0 Hz), both with an integral height of 2 represented four aromatic protons. 
A singlet at 5.14 ppm with an integral height of 2 indicated two aliphatic protons. A 
quartet at 4.21 ppm (J 7.2 Hz) with an integral height of 2 represented two aliphatic 
protons. A triplet at 1.24 ppm (J 7.2 Hz) with an integral height of 3 represented three 
methyl protons. These results were in concordance with the results for 25. 
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Equation 28 
         28(88%) 
 
Synthesis of ethyl 2-(4-((4-acetamidophenylsulfonamido)methyl)-1H-pyrazol-1-
yl)acetate (28) (Equation 28). The product was isolated as white crystals. The melting 
point was determined to 176-178oC. 1H NMR spectra of the product 28 showed a singlet 
at 10.31 ppm with an integral height of 1 that represented a secondary amide proton. A 
singlet at 8.03 ppm with an integral height of 1 indicated a sulfonamide proton. A singlet 
at 7.92 ppm with an integral height of 1 indicated a triazole proton. A multiplet at 7.80-
7.65 ppm with an integral height of 4 indicated four aromatic protons. A singlet at 5.32 
ppm with an integral height of 2 represented two aliphatic protons. A quartet at 4.17 ppm 
(J 7.1 Hz) with an integral height of 2 represented two protons in α-position to the ester. 
A singlet at 4.03 with an integral height of 2 represented two aliphatic protons. A singlet 
at 2.09 with an integral height of 3 represented three methyl protons. A triplet at 1.22 (J 
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7.1 Hz) with an integral height of 3 represented three methyl protons. 13CNMR data 
showed two peaks at 168.87 and 167.07 that indicated two carbonyl carbons. Four peaks 
at 142.67, 133.82, 127.64 and 124.61 represented 6 aromatic carbons. A peak at 118.48 
represented a triazole carbon. Five peaks at 61.35, 50.17, 38.60, 24.04 and 13.88 
represented five aliphatic carbons. There was not found a peak for the second triazole 
carbon. HRMS calcd. for C15H19N5O5S [M+]: 381.1107, found: 381.1074 
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2.2.2 1,4 Disubstituted cyclo additions 
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t-BuOH:H2O, 1:1
 
Equation 29 
       29 (74%) 
 
Synthesis of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-4-nitrobenzenesulfonamide (29). 
The melting point was determined to 144-145oC. Rf in hexane:EtOAc (1:4) was 0.56 
1H NMR spectra of the product 29 showed a singlet at 8.53 ppm with an integral height 
of 1 that represented the sulfonamide proton. A doublet at 8.31 ppm (J 9.0 Hz) with an 
integral height of 2 represented 2 benzene protons.  A doublet at 7.97 ppm (J 9.0 Hz) 
with an integral height of 2 represented two benzene protons. At 7.90 ppm a singlet with 
an integral height of 1 represented a triazole proton. A multiplet at 7.35-7.22 ppm with an 
integral height of 5 represented five aromatic protons. A singlet at 5.49 ppm with an 
integral height of 2 indicated two aliphatic protons. A singlet at 4.14 ppm with an integral 
height of 2 indicated two aliphatic protons 13C NMR data showed four peaks at 149.32 
ppm, 146.10 ppm, 135.80 ppm and 128.58 ppm that represented five aromatic carbons. 
At 128.06 ppm a peak indicated a triazole carbon. Four peaks at 127.99 ppm, 127.83 
ppm, 124.29 and 123.34 ppm indicated seven aromatic carbons. At 52.59 ppm and 37.83 
ppm two peaks indicated two aliphatic carbons. One of the peaks for the carbons on the 
triazole did not show up in the spectrum. 
 43
 S
O
O
N+
O
O-
N
HN3
S
O
O
N+
O
O-
NH
N
N
N
O2N
O2N
NaAscorbate
CuSO4
t-BuOH:H2O, 1:1
 
Equation 30 
       30 (52%) 
 
The reaction outlined in Equation 30 was performed twice. The first time over, the 
product obtained was impure. This was probably due to insufficient use of solvent. Only 
4 mL was used. 8 mL of solvent was used in the second experiment. The reaction gave 4-
nitro-N-((1-(4-nitrobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzenesulfonamide (30) in a 
52% yield. The melting point was determined to 183-185oC. Rf in hexane:EtOAc (1:4) 
was 0.36. 1H NMR spectra of the product 30 showed a singlet at 8.58 ppm with an 
integral height of 1 that represented the sulfonamide proton. A doublet at 8.31 ppm (J 8.7 
Hz) with an integral height of 2 represented two benzene protons.  A doublet at 8.22 ppm 
(J 8.7 Hz) with an integral height of 2 represented two aromatic protons. At 7.99 ppm (J 
8.4 Hz) a doublet with an integral height of 3 represented two aromatic protons and an 
overlapping triazole proton. A doublet at 7.47 ppm (J 8.7 Hz) with an integral height of 2 
represented two aromatic protons. A singlet at 5.69 ppm with an integral height of 2 
indicated two aliphatic protons. A singlet at 4.17 ppm with an integral height of 2 
indicated two aliphatic protons. 13C NMR data showed four peaks at 149.26 ppm, 147.11 
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ppm, 146.08 ppm and 143.15 ppm that represented four aromatic carbons. Four peaks at 
128.88 ppm, 127.97 ppm, 124.26 ppm and 123.70 ppm represented eight aromatic 
carbons. At 58.91 ppm and 37.82 ppm two peaks represented two aliphatic carbons.  
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Equation 31 
       31 (42%) 
 
Synthesis of 4-nitro-N-((1-(3,4,5-trimethoxybenzyl)-1H-1,2,3-triazol-4-
yl)methyl)benzenesulfonamide (31) (Equation 31). The melting point was determined to 
148-154oC. Rf in hexane:EtOAc (1:4) was 0.32. 1H NMR spectra of the product 31 
showed a singlet at 8.51 ppm with an integral height of 1 that represented the 
sulfonamide proton. A doublet at 8.34 ppm (J 9.0 Hz) with an integral height of 2 
represented two aromatic protons.  A doublet at 8.00 ppm (J 9.0 Hz) with an integral 
height of 3 represented two aromatic protons and an overlapping triazole proton. A 
singlet at 6.67 ppm with an integral height of 2 represented two aromatic protons. A 
singlet at 5.41 ppm with an integral height of 2 indicated two aliphatic protons in α-
position to benzene. A singlet at 4.12 ppm with an integral height of 2 indicated two 
aliphatic protons in α-position to the triazole. Two singlets at 3.75 ppm and 3.63 ppm 
with integral heights of 6 and 3 indicated nine methoxy protons. 13C NMR data showed 
three peaks at 152.90 ppm, 149.39 ppm and 145.95 ppm that represented four aromatic 
carbons. At 143.20 ppm a peak indicated a triazole carbon. Four peaks at 137.26 ppm, 
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131.18 ppm, 128.04 ppm and 124.31 pm indicated six aromatic carbons. At 123.30 ppm a 
peak indicated a triazole carbon. At 59.88 ppm and 55.84 ppm two peaks represented the 
three carbons in the methoxy groups. At 52.81 ppm and 37.20 ppm two peaks indicated 
two aliphatic carbons. 
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Equation 32 
         32 (58%) 
 
Synthesis of ethyl 2-(4-(hydroxy(3,4,5-trimethoxyphenyl)methyl)-1H-1,2,3-triazol-1-
yl)acetate (32) (Equation 32). NMR results indicated that a mixture of 32 and 32 without 
the hydroxyl group were formed. The product was not purified by column 
chromatography.  
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3. Experimental 
 
3.1 General procedures 
 
General procedure for click reactions 
The click reactions were performed as outlined below. The individual data are given in 
the description of the different syntheses. An azide was mixed with t-BuOH:H2O (1:1) in 
a 20 mL screw-top scintillation vial. An alkyne and sodium ascorbate was added. The 
mixture was stirred at room temperature until everything were dissolved. Finally copper 
sulphate was added, and the mixture was allowed to stir at room temperature over night. 
The reaction mixture was diluted with ice-water and a precipitate usually formed. The 
precipitate was filtered off and washed 3 times with saturated ammonium chloride 
solution and 2 times with cold diethyl ether. This was the standard procedure for isolation 
of the product, unless another method is described for the individual experiments. 
 
General procedure for one-pot click reactions 
The one-pot click reactions were performed as outlined below. The individual data are 
given in the description of the different syntheses. A bromide was mixed with t-
BuOH:H2O (1:1) in a 20 mL screw-top scintillation vial. Sodium azide, an alkyne and 
sodium ascorbate was added. The mixture was stirred at room temperature until 
everything were dissolved. Finally copper sulphate was added, and the mixture was 
allowed to stir at room temperature over night. The reaction mixture was diluted with ice-
water and a precipitate usually formed. The precipitate was filtered off and washed 3 
times with saturated ammonium chloride solution and 2 times with cold diethyl ether. 
This was the standard procedure for isolation of the product, unless another method is 
described for the individual experiments. 
 
General procedure to prepare azides 
The amounts of the different compounds and data for the individual reactions are given 
below. The experiments were carried out at room temperature. Solvent (EtOH:H2O, 1:1) 
was put in a round bottomed flask of a proper size, and the pH was measured. If the pH 
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was not around 7, some HCO3 (aq) or HCl was added. NaN3 was added to the solvent 
while stirring. The bromide was added to the mixture while stirring. The mixture stirred 
for 12 hours. EtOAc in equal volumes to the solvent was added to the mixture. The 
mixture was washed with brine in equal volumes twice. The organic phase was dried 
(MgSO4) and the organic solvent was evaporated under reduced pressure. 
 
General procedure to prepare bromides 
The amounts of the different compounds and data for the individual reactions are given 
separately in the description for each experiment. The experiments were carried out at 
under dry conditions at room temperature. The alcohol was weighed in a round bottomed 
flask of suitable size and it was flushed with Argon. Dichloromethane was added to the 
round bottomed flask via a syringe. Trietylamine was added via a syringe while stirring. 
Bromoacetylchloride was added drop by drop via a syringe. The mixture was allowed to 
stir over night. NaHCO3 (10%) was added until the bobbling stopped. The mixture was 
washed with brine. The organic phase was dried (MgSO4) and the solvent was evaporated 
under reduced pressure. Column chromatography was performed on the products. 
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3.2 Synthesis 
 
(3,4,5-Trimethoxy)methanol (1) 
    
MeO
OMe
OMe
CH2OH
 
 
NaBH4 (0.76g, 20 mmol) was dissolved in EtOH:H2O (1:1, 20 mL) while stirring at 0ºC. 
3,4,5-Trimethoxybenzaldehyde (7.85 g, 40mmol) was dissolved in THF:EtOH (1:3, 60 
ml). The NaBH4 solution was added, in small portions, to the  
3,4,5-trimethoxybenzaldehyde solution  at 0ºC while stirring. After 5 min. the ice bath 
was removed, and the mixture was stirred at room temperature for 2.5 hours. The reaction 
was quenched with ice. The mixture was acidified to pH 1 with HCl (conc.), extracted 
with EtOAc (3x100 mL), washed with brine (2x100 mL) and dried (MgSO4). The MgSO4 
was filtered off and the solvent was evaporated under reduced pressure furnishing 8.03 g 
(total yield 100%) as a slightly yellow colored oil. 1H NMR (CDCl3, 300 MHz) δ 6.58 (s, 
2H), 4.62 (s, 2H), 3.85 (s, 6H), 3.82 (s, 3H), 2.03 (s, 1H); 13C NMR (CDCl3, 75 MHz) δ 
153.30, 137.23, 136.63, 103.75, 65.43, 60.80, 56.03. 
 
5-(bromomethyl)-1,2,3-trimethoxybenzene (2) 
    
MeO
OMe
OMe
CH2Br
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The experiment was performed under dry conditions. (3,4,5-Trimethoxy)methanol 
(0.99g, 5 mmol) was dissolved in dichloromethane (10 mL) while stirring. CBr4 (1.70g, 6 
mmol) was added and dissolved.  The mixture was put on an ice bath and the flask was 
flushed with argon. Triphenylphosphin (1.71g, 6.5 mmol) was added in small portions. 
The mixture was taken off the ice bath and was left to stir for over night at room 
temperature.  The mixture was washed with hexane (2x 20 mL) and CHCl3 (2x20 mL), 
this caused precipitation. The mixture was filtered through silica 2x. The solvent was 
evaporated under reduced pressure, furnishing 3.92g (total yield 58%) as white crystals. 
Mp: 74-75oC; 1H NMR (CDCl3, 300 MHz) δ 6.58 (s, 2H), δ 4.62 (s, 2H), δ 3.85 (s, 6H), δ 
3.82 (s, 3H), δ 2.03 (s, 1H); 13C NMR (CDCl3, 75 MHz) δ 153.30, 137.23, 136.63, 
103.75, 65.43, 60.80, 56.03. 
 
1,2,3-trimethoxy-5-(prop-2-ynyl)benzene (3) 
    OMe
OMeMeO
 
 
The experiment was performed under dry conditions. 5-(bromomethyl)-1,2-dimethoxy-3-
methylbenzene (0.66g, 2 mmol) and CuI (0.04g, 0.2 mmol) was weighed out in a flask. 
The flask was flushed with N2. Dry THF (10 mL) was added and the mixture was stirred 
until the solids dissolved. Ethynylmagnesium bromide in THF (0.5M, 8 mL) was added. 
The mixture was stirred for 48 hours at 58oC. TLC showed that no product was formed. 
The experiment was aborted. 
 
1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol (4)   
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OMe
OMeMeO
HO
 
 
The experiment was performed under dry conditions. 3,4,5-trimethoxybenzaldehyde 
(1.96g, 10 mmol) and was weighed out in a flask. The flask was flushed with Argon. Dry 
THF (20 mL) was added and the mixture was stirred until the solid dissolved. The 
mixture was put on an ice bath. Ethynylmagnesium bromide in THF (0.5M, 24 mL) was 
added. The mixture was stirred for 1 hour at 0oC. After 1 hour the ice bath was removed 
and the mixture was stirred over night. TLC showed that product was formed. NH4Cl (20 
mL) was added. The organic phase and the water phase were separated. The water phase 
was extracted twice with diethyl ether and washed with brine. The organic phase was 
collected and dried (MgSO4) and the solvent was evaporated under reduced pressure. 
Flashcromatography was performed, furnishing 1.96g (total yield 88%) as white crystals; 
Rf 0.42 (hexane:EtOAc, 1:1); 1H NMR (CDCl3, 300 MHz) δ 6.80 (s, 2H), 4.62 (s, 1H), 
3.89 (s, 6H), 3.85 (s, 3H), 2.69 (d, J 2.1 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 153.87, 
138.10, 135.56, 103.64, 83.56, 74.89, 64.56, 60.84, 56.15.  
 
 
5-ethynyl-1,2,3-trimethoxybenzene (5)  
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H3CO
OCH3
OCH3
 
 
The experiment was performed under dry conditions. A bath of acetone and dry ice was 
prepared. A 250 mL round bottomed flask was flushed with Argon and put in the 
acetone/dry ice bath. [(CH3)2CH]2NLi (1.8 M, 23.3 mL)  measured out and transferred to 
the round bottomed flask. C4H10N2Si (2.0 M, 18.8 mL) was carefully added. After 15 
minutes, 3,4,5-trimethoxybenzaldehyde (5.89 g, 30 mmol) was weighed out and 
dissolved in dry THF and added drop by drop to the mixture. The mixture was allowed to 
stir over night at -78oC. The mixture was brought to room temperature. Brine (30 mL) 
was added and the mixture was extracted with EtOAc (3 x 100 mL). The organic phase 
was washed with brine (2 x 100 mL). The organic phase was collected and dried 
(MgSO4) and the solvent was evaporated under reduced pressure. Column 
chromatography was performed, furnishing 3.69 g (total yield 64%) as white crystals; mp 
93-95oC; Rf  0.50 (Hexane:EtOAc 8:3); 1H NMR (CDCl3, 300 MHz) δ 6.73 (s, 2H),  3.85  
(s, 9H),  3.03 (s,  1H); 13C NMR (CDCl3, 75 MHz) δ 153.04, 139.30, 117.01, 109.36, 
83.70, 76.19, 60.95, 56.15; HRMS calcd. for Chemical Formula: C11H12O3 [M+]: 
192.0786, found: 192.0780. 
 
Ethyl prop-2-ynylcarbamate (6) 
N
H
O
O
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An ice bath was prepared. Propargylamine (0.54 g, 5 mmol) was dissolved in 
dichloromethane (5 mL). Ethylchloroformate (0.27 g, 5 mmol) was dissolved in 
dichloromethane (5 mL). The Propargylamine solution was added to the 
Ethylchloroformate solution drop by drop while stirring at 0oC. The mixture was stirred 
over night at room temperature. EtOAc (50 mL) was added. The mixture was washed 
with NaHCO3 (20%, 2 x 50 mL). The organic phase was dried (MgSO4) and the solvent 
was evaporated under reduced. NMR data indicated that only starting materials were 
isolated. 
 
N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (7)  
S
O
O
N
H
H
N O
 
 
An ice bath prepared. Propargylamine (0.20 g, 2 mmol) was weighed in 25 mL round 
bottomed flask. Pyridine (1 mL) was added, and the solution was stirred at 0oC. N-(4-(N-
prop-2-ynylsulfamoyl)phenyl)acetamide (0.43 g, 1.85 mmol) was added in small 
portions. The mixture was stirred over night at room temperature. HCl (1M, 10 mL) and 
EtOAc (20 mL) was added. The organic phase was washed with HCl (1 M, 10 x 10 mL). 
The organic phase was dried (MgSO4) and the solvent was evaporated under reduced 
pressure, furnishing 0.11 g (total yield 24%) as pink crystals; mp 192-193oC; Rf  0.40 
(Hexane:EtOAc 1:5); 1H NMR (d-Aceton, 300MHz) δ= 9.49 (s, 1H), 7.84-7.77 (m, 4H), 
3.81-3.79 (m, 2H), 2.12 (s, 3H), 2.09 (s, 1H); 13C NMR (d-Aceton, 75 MHz) δ 170.50, 
145.15, 136.45, 130.08, 120.37, 80.73, 74.63, 34.13, 25.38; HRMS calcd. for 
C11H12N2O3S [M+]: 252.0569 found: 252.0565. 
 
N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (7)  
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SO
O
N
H
H
N O
 
 
Large scale preparation of (7): an ice bath prepared. Propargylamine (2.48 g, 45 mmol) 
was weighed in 250 mL round bottomed flask. Pyridine (40 mL) was added, and the 
solution was stirred at 0oC. The round bottomed flask was flushed with Argon. N-(4-(N-
prop-2-ynylsulfamoyl)phenyl)acetamide (6.71g, 30 mmol) was added in small portions. 
The mixture was stirred over night at room temperature. HCl (2 M, 70 mL) and EtOAc 
(100 mL) was added. The organic phase was washed with HCl (2 M, 10 x 70 mL). The 
resulting precipitate was filtered off, furnishing 3.25 g (total yield 43%) as pink crystals; 
mp 192-193oC; Rf  0.40 (Hexane:EtOAc 1:5); 1H NMR (CDCl3, 300 MHz) δ 9.50 (s, 
1H), 7.84-7.77  (m, 4H),  3.81-3.79 (m,  2H), 2.12 (s, 3H), 2.01 (s, 1H); 13C NMR 
(CDCl3, 75 MHz) δ 170.50, 145.15, 136.45, 130.08, 120.37, 80.73, 74.63, 34.13, 25.38; 
HRMS calcd. for C11H12N2O3S [M+]: 252.0569 found: 252.0565. 
 
4-nitro-N-(prop-2-ynyl)benzenesulfonamide (8) 
 
S
O
O
N+
O
O-
HN
 
 
An ice bath prepared. Propargylamine (1.69 g, 30 mmol) was weighed in 250 mL round 
bottomed flask. Pyridine (30 mL) was added, and the solution was stirred at 0oC. The 
round bottomed flask was flushed with Argon. 4-nitrobenzene-1-sulfonyl chloride (4.93 
g, 20 mmol) was added in small portions. The mixture was stirred over night at room 
temperature. HCl (2 M, 70 mL) and EtOAc (100 mL) was added. The organic phase was 
washed with HCl (2 M, 10 x 70 mL). The mixture was brought to pH 7 with NaOH 
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(6M).The resulting precipitate was filtered off, furnishing 3.12 g (total yield 61%) as a 
yellow solid; mp 152-154oC; Rf 0.33 (Hexane:EtOAc, 2:1); 1H NMR (DMSO, 200 MHz) 
δ 8.54 (t, J 5.8 Hz, 1H), 8.45-8.38 (m, 2H), 8.09-8.04 (m, 2H), 3.79 (dd, J 2.6, 2H), 3.01 
(t, J 2.6 Hz, 1H); 13C NMR (DMSO, 75 MHz) δ 149.53, 146.18, 128.34, 124.29, 78.72, 
75.09, 31,81. 
 
4-nitro-N-(prop-2-ynyl)benzenesulfonamide (8) 
 
S
O
O
N+
O
O-
HN
 
 
Propargylamine (0.23 g, 4 mmol) was weighed in 100 mL round bottomed flask. 4-
nitrobenzene-1-sulfonyl chloride (0.99 g, 4 mmol) and water (20 mL) was added. The pH 
of the mixture was adjusted to 8 with Na2CO3. The mixture was stirred at room 
temperature and Na2CO3 was added to keep the pH at 8. After 2 hours the reaction was 
stopped by adding HCl (12 M, 1 mL). The resulting precipitate was filtered off and 
washed with water.  
 
 
4-amino-N-(prop-2-ynyl)benzenesulfonamide (9) 
S
O
O
N
H
NH2
 
 
N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (1.51 g, 6 mmol) and NaOH (10 M, 60 
mL) was refluxed 3 hours in a 250 mL round bottomed flask with a cooler. The mixture 
was neutralized with HCl (3 M). NaOH (0.01 M) was added to make the mixture slightly 
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alkaline. The mixture was extracted with chloroform (3 x 100 mL), but the product did 
not distribute in the organic phase. The water phase was evaporated under reduced 
pressure and the resulting solid was dissolved in methanol. The solution was filtered 
through a “plug” of MgSO4, celite and silica. Rf  0.38 (Hexane:EtOAc 1:4); 1H NMR (d6-
MeOH, 300 MHz); δ 7.53 (d, J 8.7 Hz, 2H), 6.69 (d, J 9.0 Hz, 2H), 3.65 (d, J 2.7 Hz, 
2H), 2.47 (t, J 2.7 Hz, 1H), 2.16 (s, 1H); 13C NMR (d6-MeOH, 75 MHz) δ 154.28, 
130.92, 127.12, 114.43, 79.93, 73.34, 33.18; HRMS calcd. for C9H10N2O2S [M+]: 
210.0463, found: 210.0457. 
 
Ethyl 2-azidoacetate (10) 
O
ON3  
 
Ethyl 2-azidoacetate was prepared according to the general procedure for azides from 
ethyl 2-bromoacetate (0.84 g, 5 mmol) and sodium azide (0.34 g, 5.25 mmol), furnishing 
0.37 g (55%) as a colorless liquid. IR: 2109 cm-1, 1747 cm-1; 1H NMR (CDCl3, 300 MHz) 
δ 4.24 (q, J 6.9 Hz, 2 H), 3.84 (s, 2H), 1.29 (d, J 6.9 Hz, 3H); 13C NMR (CDCl3, 75 
MHz) δ 168.21, 61.79, 50.29, 14.05; HRMS calcd. for C4H7N3O2 [M+]: 129.0538, found: 
129.0539. 
 
(Azidomethyl)benzene (11) 
N3
 
 
(Azidomethyl)benzene was prepared according to the general procedure for azides from 
benzyl bromide (3.42 g, 20 mmol) and sodium azide (1.37 g, 21 mmol), EtOH:H2O (1;1, 
80 mL). The reaction yielded 2.28 g (86%) as a yellow liquid; Rf  0.80 (Hexane:EtOAc 
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2:1); 1H NMR (CDCl3, 300 MHz) δ 7.43-7.30 (m, 5 H), 4.35 (s, 2H); 13C NMR (CDCl3, 
75 MHz) δ 135.35, 128.82, 128.29, 128.20, 54.80 
 
1-(Azidomethyl)-4-nitrobenzene (12) 
N+
O O-
N3  
 
1-(Azidomethyl)-4-nitrobenzene was prepared according to the general procedure for 
azides from 4-nitrobenzyl bromide (3.42 g, 20 mmol) and sodium azide (1.37 g, 21 
mmol), The reaction yielded 3.56 g (89%) as a yellow liquid; Rf  0.74 (Hexane:EtOAc 
1:4); 1H NMR (CDCl3, 300 MHz) δ 8.26-8.19 (m, 2 H), 7.58-7.48 (m, 2H), 4.51 (s,2H); 
13C NMR (CDCl3, 75 MHz) δ 144.74, 142.67, 129.89, 124.03, 53.72 ; HRMS calc for 
C6H6N4O2: 178.0491, found: 178.0490. 
 
4-(Azidomethyl)pyridine (13) 
N
N3
 
 
The reaction was performed with dry conditions under Argon. 4-Pyridylcarbinol (0.22 g, 
2 mmol) was weighed in a 25 mL round bottomed flask and diphenyl phosphorazide 
(0.66 g, 2.4 mmol) was added via a syringe. Dry toluene (4 mL) was added via a syringe. 
The mixture was put on an ice bath. DBU (0.37 g, 2.4 mmol) was added via a syringe. 
The mixture stirred for 2 hours at 0oC, and then for another 20 hours at room temperature. 
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EtOAc (1 mL) was added and the mixture was extracted with toluene (3 x 7 mL), the 
organic phase was evaporated under reduced pressure. A white crystalline powder was 
obtained, but it was insoluble in all available deuterated solvents, hence no NMR results 
were obtained. The experiment was aborted.  
 
3-(Azidomethyl)pyridine (14) 
N3
N
 
 
The reaction was performed with dry conditions under Argon. 3-Pyridylcarbinol (1.09 g, 
10 mmol) was weighed in a 100 mL round bottomed flask and diphenyl phosphorazide 
(3.30 g, 12 mmol) was added via a syringe. Dry toluene (18 mL) was added via a syringe. 
The mixture was put on an ice bath. DBU (1.83 g, 12 mmol) was added via a syringe. 
The mixture stirred for 4 hours at 0oC, and then for another 20 hours at room temperature. 
The mixture was washed with water first, and then with HCl. This procedure resulted in 3 
phases. The experiment was aborted. 
 
3-(Bromomethyl)pyridine (15) 
N
Br  
 
3-(Bromomethyl-)pyridine hydrobromide (0.52 g, 2 mmol) was weighed in a 25 mL 
round bottomed flask and EtOH:H2O, 1:1 (4 mL) was added. The mixture was allowed to 
stir at room temperature. NaOH (1 M) was added until the pH reached 8.The mixture 
stirred over night. A white precipitate was observed, but extraction with EtOAc did not 
succeed and the experiment was aborted. 
 
2-Bromophenyl 2-bromoacetate (16) 
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OBrOBr
 
 
The reaction was performed according to the general procedure for bromides. Chemicals 
and amounts used: Bromoacetylchloride (1.73 g, 11 mmol), 2-bromphenol (1.73 g, 10 
mmol), triethylamine (1.11 g, 11 mmol) and dichloromethane (20 mL). The reaction 
furnished 0.87 g (30%) as a colorless liquid. Rf 0.60 (hexane:EtOAc, 3:1); 1H NMR 
(CDCl3, 300 MHz) δ 7.62 (d, J 7.8 Hz, 1H) 7.35 (t, J 8.1 Hz, 1H) 7.18-7.13 (m, 2H) 4.37 
(s, 2H)  ; 13C NMR (CDCl3, 75 MHz) δ 164.96, 147.62, 133.44 ppm, 128.59, 127.85, 
123.31, 115.71, 25.05. 
  
Methyl 3-(4-(2-bromoacetoxy)phenyl)propanoate (17) 
O
Br
O
O
O
 
 
The reaction was performed according to the general procedure for bromides. Chemicals 
and amounts used: Bromoacetylchloride (1.73 g, 11 mmol), methyl 3-(4-
hydroxyphenyl)propanoate (1.80 g, 10 mmol), triethylamine (1.11 g, 11 mmol) and 
dichloromethane (20 mL). The reaction furnished 0.72 g (24%) as a white solid. Mp; 54-
55oC; Rf 0.38 (hexane:EtOAc, 3:1); 1H NMR (CDCl3, 300 MHz) δ 7.23 (d, J 8.7 Hz, 2H) 
7.05 (d, J 8.7 Hz, 2H) 4.27 (s, 2H), 3.67 (s, 3H), 2.96 (t, J 8.1 Hz, 2H),  2.63 (t, J 7.8 Hz, 
2H)  ; 13C NMR (CDCl3, 75 MHz) δ 173.06, 165.91, 148.71, 138.71, 129.41, 121.07, 
51.65, 40.85, 35.52, 30.25. 
 
Ethyl 2-(4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-1-yl)acetate (18) 
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MeO
MeO OMe
N
N
N
O
O
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl 2-bromoacetate (167 mg, 1 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium 
azide (65 mg, 1.05 mmol), 5-ethynyl-1,2,3-trimethoxystilbene (192 mg, 1mmol), sodium 
ascorbate (20 mg, 0.1 mmol) and copper sulphate (13 mg, 0.05 mmol). TLC showed that 
the reaction was not completed. Sodium azide (38 mg, 0.5 mmol), sodium ascorbate (10 
mg, 0.05 mmol) and copper sulphate (7 mg, 0.025 mmol) were added. The mixture was 
allowed to stir over night. The reaction mixture was diluted with ice-water and EtOAc 
(20 mL) was added. The organic phase was washed 3 times with saturated ammonium 
chloride solution (10 mL). The organic phase was dried (MgSO4) and filtered. The 
solvent was evaporated under reduced pressure, furnishing 165 mg (total yield 52%) as 
slightly yellow colored crystals. Mp: 95-97oC; Rf 0.66 (Hexane:EtOAc, 1:10); 1H NMR 
(CDCl3, 300MHz); δ 7.90 (s, 1H), 7.06 (s, 2H), 5.20 (s, 2H), 4.29 (q, J 7.8 Hz, 2H), 3.92 
(s, 6H), 3.87 (s, 3H), 1.31 (t, J 7.8 Hz, 3H); 13C NMR (CDCl3, 300MHz); δ 166.27, 
153.62, 138.24, 125.84, 120.77, 103.04, 62.50, 60.92, 56.24, 50.97, 14.06. A peak for the 
second triazole carbon was not found in the spectrum. HRMS calc for C15H19N3O5: 
321.1325, found; 321.1330. 
 
Ethyl 2-(4-(hydroxy(3,4,5-trimethoxyphenyl)methyl)-1H-1,2,3-triazol-1-yl)acetate 
(19) 
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OMeMeO
MeO
HO
N
N
N
O
O
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl 2-bromoacetate (668 mg, 4 mmol), t-BuOH:H2O solution (1:1,16 mL), sodium 
azide (260 mg, 4.2 mmol), 1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol (889 mg, 4mmol), 
sodium ascorbate (79 mg, 0.4 mmol) and copper sulphate (50 mg, 0.2 mmol). The 
mixture was diluted with ice water and washed with saturated ammonium chloride 
solution (3 x 30 mL). The mixture was extracted with dichloromethane (2 x 50 mL), the 
organic phase was dried (MgSO4) and evaporated under reduced pressure. NMR data 
showed that only starting materials were isolated. 
 
Diethyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)malonate (20) 
N
N
N
O
O
O
O
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The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Diethyl 2-bromomalonate (476 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium 
azide (137 mg, 2.1 mmol), phenylacetylene (204 mg, 2 mmol), sodium ascorbate (40 mg, 
0.2 mmol) and copper sulphate (25 mg, 0.1 mmol). The mixture was diluted with ice-
water and washed with saturated ammonium chloride solution (3 x 15 mL). The mixture 
was extracted with EtOAc (3 x 20 mL). 
The organic phase was dried (MgSO4) and filtered. The solvent was evaporated under 
reduced pressure, a yellow liquid was obtained. NMR data showed that the product was 
not pure.  
 
Ethyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)propanoate (21) 
N
N
N O
O
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl-2-bromopropionate (362 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium 
azide (137 mg, 2.1 mmol), phenylacetylene (204 mg, 2 mmol), sodium ascorbate (40 mg, 
0.2 mmol) and copper sulphate (25 mg, 0.1 mmol). The mixture was diluted with ice-
water and washed with saturated ammonium chloride solution (3 x 15 mL). The mixture 
was extracted with EtOAc (3 x 20 mL). The organic phase was dried (MgSO4) and 
filtered. The solvent was evaporated under reduced pressure, a green liquid was obtained. 
NMR data showed that the product was not pure.  
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 Ethyl 2-phenyl-2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate (22) 
 
N
N
N
O
O
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl bromphenylacetate (486 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium 
azide (137 mg, 2.1 mmol), phenylacetylene (204 mg, 2 mmol), sodium ascorbate (40 mg, 
0.2 mmol) and copper sulphate (25 mg, 0.1 mmol). The mixture was diluted with ice-
water and washed with saturated ammonium chloride solution (3 x 15 mL). The mixture 
was extracted with EtOAc (3 x 20 mL). The organic phase was dried (MgSO4) and 
filtered. The solvent was evaporated under reduced pressure, a green liquid was obtained. 
NMR data showed that the product was not pure.  
 
2-Bromophenyl 2-(4-((4-acetamidophenylsulfonamido)methyl)-1H-1,2,3-triazol-1-
yl)acetate (23) 
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SO
O
N
H
H
N O
O
Br
O
N
N N  
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. Chemicals: 2-Bromophenyl 2-
bromoacetate (294 mg, 1 mmol), t-BuOH:H2O solution (1:1, 2 mL), sodium azide (68 
mg, 1.05 mmol), N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (252 mg, 1 mmol), 
sodium ascorbate (20 mg, 0.1 mmol) and copper sulphate (12 mg, 0.05 mmol). The 
mixture was diluted with ice-water and washed with saturated ammonium chloride 
solution (3 x 10 mL). The mixture was extracted with EtOAc (3 x 15 mL). The organic 
phase was dried (MgSO4) and filtered. NMR data showed that no product was isolated.  
 
2-Bromophenyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate (24) 
O
BrO
N
N
N
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. Chemicals: 2-Bromophenyl 2-
bromoacetate (294 mg, 1 mmol), t-BuOH:H2O solution (1:1, 2 mL), sodium azide (68 
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mg, 1.05 mmol), phenylacetylene (102 mg, 1 mmol), sodium ascorbate (20 mg, 0.1 
mmol) and copper sulphate (12 mg, 0.05 mmol). The mixture was diluted with ice-water 
and washed with saturated ammonium chloride solution (3 x 10 mL). The mixture was 
extracted with EtOAc (3 x 15 mL). TLC showed that no product was formed, and the 
experiment was aborted. 
 
Ethyl 2-(4-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)acetate (25) 
O2N
O O
N
N
N
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. Ethyl bromoacetate (332 mg, 2 
mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium azide (137 mg, 2.1 mmol), 1-ethynyl-
4-nitrobenzene (97%, 303 mg, 2 mmol), sodium ascorbate (40 mg, 0.2 mmol) and copper 
sulphate (25 mg, 0.1 mmol). Total yield 292 mg (53%); mp 144-145oC; Rf  0.66 
(Hexane:EtOAc 1:4); 1H NMR (DMSO, 300 MHz) δ 8.85 (s, 1H),  8.32  (d, J 9.0 Hz, 
2H), 8.14 (d, J 9.0 Hz, 2H), 5.52 (s, 2H), 4.21 (q, J 7.2 Hz, 2H), 1.24 (t, J 7.2 Hz, 3H); 
13C NMR (CDCl3, 75 MHz) δ 166.98, 146.59, 144.38, 136.79, 128.33, 125.94, 124.23, 
61.58, 50.63, 13.89. 
Ethyl 2-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)acetate (26) 
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The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl bromoacetate (332 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium azide 
(137 mg, 2.1 mmol), 1-ethynyl-3-fluorobenzene (98%, 245 mg, 2 mmol), sodium 
ascorbate (40 mg, 0.2 mmol) and copper sulphate (25 mg, 0.1 mmol). Total yield 209 mg 
(42%) as a slightly green solid; Mp: over 250oC; Rf 0.72 (hexane:EtOAc, 1:4); 1H NMR 
(DMSO, 300 MHz) δ 8.68 (s, 1H),  7.72-7.14 (m, 4H), 5.47 (s, 2H), 4.20 (q, J 7.2 Hz, 
2H), 1.04 (t, J 7.2 Hz, 3H); HRMS calcd. for: C12H12FN3O2 [M+]: 249.0914, found: 
249.0913. 
 
Ethyl 2-(4-(4-nitrophenyl)-1H-1,2,3-triazol-1-yl)acetate (25) 
O2N
O O
N
N
N
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions, 
at a temperature of 40oC. The chemicals used and the data is described below. Ethyl 
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bromoacetate (664 mg, 4 mmol), t-BuOH:H2O solution (1:1, 8 mL), sodium azide (273 
mg, 4.2 mmol), 1-ethynyl-4-nitrobenzene (97%, 606 mg, 4 mmol), sodium ascorbate (80 
mg, 0.4 mmol) and copper sulphate (50 mg, 0.2 mmol). Total yield 961 mg (87%); mp 
144-145oC; Rf  0.66 (Hexane:EtOAc 1:4); 1H NMR (DMSO, 300 MHz) δ 8.85 (s, 1H),  
8.32  (d, J 9.0 Hz, 2H), 8.14 (d, J 9.0 Hz, 2H), 5.52 (s, 2H), 4.21 (q, J 7.2 Hz, 2H), 1.24 
(t, J 7.2 Hz, 3H); 13C NMR (DMSO, 75 MHz) δ 166.98, 146.59, 144.38, 136.79, 128.33, 
125.94, 124.23, 61.58, 50.63, 13.89.. 
 
Ethyl 2-(4-((4-acetamidophenylsulfonamido)methyl)-1H-pyrazol-1-yl)acetate (28) 
S
O
ON
H
H
N
O
N
N
NO
O
 
 
The reaction was performed as outlined in general procedure for one-pot click reactions. 
The chemicals used and the data is described below. 
Ethyl bromoacetate (166 mg, 1 mmol), t-BuOH:H2O solution (1:1, 4 mL), sodium azide 
(68 mg, 1.05 mmol), N-(4-(N-prop-2-ynylsulfamoyl)phenyl)acetamide (252 mg, 1 
mmol), sodium ascorbate (20 mg, 0.1 mmol) and copper sulphate (13 mg, 0.05 mmol). 
Total yield 221 mg (88%); mp 176-178oC; 1H NMR (DMSO, 300 MHz) δ 10.31 (s, 1H),  
8.03 (s, 1H), 7.92 (s, 1H), 7.80-7.65 (m, 4H), 5.32 (s, 2H), 4.17 (q, J 7.1 Hz, 2H), 4.03 (s, 
2H), 2.09 (s, 3H), 1.22 (t, J 7.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ 168.87, 167.07, 
142.67, 133.82, 127.64, 124.61, 118.48, 61.35, 50.17, 38.60, 24.04, 13.88; HRMS calcd. 
for C15H19N5O5S [M+]: 381.1107, found: 381.1074. 
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N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-4-nitrobenzenesulfonamide (29) 
S
O
O
N+
O
O-
H
N
N
N
N  
 
The reaction was performed as outlined in general procedure for click reactions. The 
chemicals used and the data is described below. 
(Azidomethyl)benzene (266 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), 4-nitro-N-
(prop-2-ynyl)benzenesulfonamide (509 mg, 2 mmol), sodium ascorbate (40 mg, 0.2 
mmol) and copper sulphate (25 mg, 0.1 mmol).  A total yield 572 mg (77%) as a yellow 
solid. Rf 0.56 (hexane:EtOAc (1:4); mp 157-158oC; 1H NMR (DMSO, 300 MHz) δ 8.53 
(s, 1H), 8.31 (d, J 9.0 Hz, 2H), 7.97 (d, J 9.0 Hz, 2H), 7.90 (s, 1H), 7.35-7.22 (m, 5H), 
5.49 (s, 2H), 4.14 (s, 2H); 13C NMR (DMSO, 75 MHz) δ 149.32, 146.10, 135.80, 128.58, 
128.06, 127.99, 127.83, 124.29,123.34, 52.59, 37.83.  
 
1-(1-(4-Nitrobenzyl)-1H-1,2,3-triazol-4-yl)-N-((4-
nitrophenylsulfonyl)methyl)methanamine (30)  
 
S
O
O
N+
O
O-NH
N
N
N
O2N
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The reaction was performed as outlined in general procedure for click reactions. The 
chemicals used and the data is described below. Chemicals: 1-(Azidomethyl)-4-
nitrobenzene 356 mg, 2 mmol), t-BuOH:H2O solution (1:1, 4 mL), 4-nitro-N-(prop-2-
ynyl)benzenesulfonamide (509 mg, 2 mmol), sodium ascorbate (40 mg, 0.2 mmol) and 
copper sulphate (25 mg, 0.1 mmol). The reaction provided a poor yield and TLC showed 
that the product was impure. 
 
1-(1-(4-Nitrobenzyl)-1H-1,2,3-triazol-4-yl)-N-((4-
nitrophenylsulfonyl)methyl)methanamine (30)  
 
S
O
O
N+
O
O-NH
N
N
N
O2N
 
 
The reaction was performed as outlined in general procedure for click reactions. The 
chemicals used and the data is described below. Chemicals: 1-(Azidomethyl)-4-
nitrobenzene 356 mg, 2 mmol), t-BuOH:H2O solution (1:1, 8 mL), 4-nitro-N-(prop-2-
ynyl)benzenesulfonamide (509 mg, 2 mmol), sodium ascorbate (40 mg, 0.2 mmol) and 
copper sulphate (25 mg, 0.1 mmol). A total yield 572 mg (77%) as a yellow solid. Rf  
0.36 (hexane:EtOAc, 1:4); mp 183-185oC; 1H NMR (DMSO, 300 MHz) δ 8.58 (s, 1H), 
8.31 (d, J 8.7 Hz, 2H), 8.22 (d, J 9.0 Hz, 2H), 7.99 (d, J 8.4 Hz, 3H),  7.47 (d, J 8.7 Hz, 
2H), 5.69 (s, 2H), 4.17 (s, 2H); 13C NMR (DMSO, 75 MHz) δ 149.26, 147.11, 146.08, 
143.15, 128.88, 127.97, 124.26, 123.70, 58.91, 37.82. 
 
4-Nitro-N-((1-(3,4,5-trimethoxybenzyl)-1H-1,2,3-triazol-4-
yl)methyl)benzenesulfonamide (31) 
 69
SO
O
N+
O
O-
NH
N
N
N
OMe
MeO
MeO
 
 
H2O (20 mL), 4-nitrobenzene-1-sulfonyl chloride (492 mg, 2 mmol) and propargylamine 
(112 mg, 2 mmol) was mixed in 250 mL round bottomed flask. The pH was set to 8 with 
Na2CO3. 5-(Azidomethyl)-1,2,3-trimethoxybenzene (442 mg, 2 mmol), sodium ascorbate 
(40 mg, 0.2 mmol), EtOH (20 mL) and copper sulphate (25 mg, 0.1 mmol) was added. 
The mixture was allowed to stir over night. Ice water was added and a precipitate formed. 
The precipitate was filtered off and washed with ammonium solution (5%, 3 x 25 mL) 
and cold diethyl ether (3 x 25 mL), furnishing a white solid total yield 400 mg (43%). Rf; 
0.32 (hexane:EtOAc, 1:4); mp 148-152oC; 1H NMR (DMSO, 300 MHz) δ 8.5 (s, 1H), 
8.34 (d, J 9.0 Hz, 2H), 8.00 (d, J 9.0 Hz, 3H),  6.67 (s, 2H), 5.41 (s, 2H), 4.12 (s, 2H), 
3.75 (s, 6H), 3.63 (s,3H); 13C NMR (DMSO, 75 MHz) δ 152.90, 149.39, 145.95, 143.20, 
137.26, 131.18, 128.04, 124.31, 123.30, 59.88, 55.84, 52.81, 37.20;  
 
Ethyl 2-(4-(hydroxy(3,4,5-trimethoxyphenyl)methyl)-1H-1,2,3-triazol-1-yl)acetate 
(32) 
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The reaction was performed as outlined in general procedure for click reactions. The 
chemicals used and the data is described below. Ethyl 2-azidoacetate (259 mg, 2 mmol), 
t-BuOH:H2O solution (1:1, 8 mL), 1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol (445 mg, 2 
mmol), sodium ascorbate (40 mg, 0.2 mmol) and copper sulphate (25 mg, 0.1 mmol).  
 
 
 
 
 
 
 
 
 
 
 
 
 71
4 Further studies and conclusion 
 
4.1 Further studies 
 
In order to obtain antibacterial activity for the prepared sulfonamides 28, 29, 30 and 31, 
hydrolysis of the amide group or reduction of the nitro group needs to be done. Due to 
time limits, these two reactions were not performed. This chemistry should be possible to 
do with established methods. In preliminary studies, hydrolysis of sulfonamide 9 in basic  
aqueous conditions afforded the desired sulfonamide product. However, this sulfonamide 
was difficult to obtain without sodium chloride as a contaminant, and further studies 
should be done in order to obtain libraries of pure sulfonamides. 
 
This one-pot methodology was employed for a wide range of substituted terminal alkynes 
in our group as depicted in Scheme 1.32 
O
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Scheme 1 
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4.2 Conclusion 
 
A one-pot procedure for the direct conversion of α-halo esters to 1,2,3-triazoles has been 
developed. These reactions were efficiently performed in neutral aqueous solutions (pH= 
7-8) at ambient temperature. Molar equivalents of the halide, sodium azide and alkyne 
are employed in this mild 1,3-dipolar cycloaddition reaction. The method circumvents the 
problems encountered with the isolation of organic azides, and complements other 
recently published methods for the preparation of 1,2,3-triazoles.33-35 The operational 
simplicity of this method makes it attractive for preparative applications as well as for the 
synthesis of screening libraries for drug discovery. 
 This method should be useful for preparation of libraries of biologically active 
compounds, for example for sulfonamides such as 7, 8 and 9. Furthermore, the 
advantages of the guiding principles of click chemistry, as exemplified for the Cu(I)-
catalyzed cycloaddition between azides and terminal alkynes, has been used for the 
preparation of several new 1,4-disubstituted 1,2,3-triazoles. 
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